| Application no. and date | 10182575.0 (espacenet) (Federated) (European Patent Register), 19981130 | | Patent/reg. no. and date | DK/EP 2305282, 20130710 | | Publication date | 20110406 | | Priority no. and date | US 67740 P, 19971202, US 80970 P, 19980407 | | EP pub. no. and date |
EP 2305282 20110406 | | Effective date | | | Applicant/owner | Janssen Alzheimer Immunotherapy, Airton Road
Tallaght
Dublin 24, IE | | Applicant ref. no. | P81307278DK00E | | Inventor | Schenk, Dale B., 1542 Los Altos Drive
Burlingame, CA 94010, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 33/06 (2006.01) , A61K 38/00 (2006.01) , A61K 38/28 (2006.01) , A61K 9/26 (2006.01) | | Title | Forebyggelse og behandling af amyloidogen sygdom | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
